SCHEMBL4756983

SCHEMBL4756983

Cc1cc(I)cc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 7/20 0.40
RAB9A P51151 7/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
PKM P14618 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
DRD4 P21917 1/20 0.39
TSPO P30536 1/20 0.39
ADORA1 P30542 1/20 0.39
DRD3 P35462 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
GCK P35557 1/20 0.38
POLB P06746 2/20 0.38
FBP1 P09467 1/20 0.38
PAX8 Q06710 1/20 0.37
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114373 0.83 GCK (0.40) FFAR2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4756952 0.81 RAB9A (0.57) SMN1; SMN2NPC1RAB9ALMNAMEN1
SCHEMBL4757155 0.81 NPC1 (0.59) FFAR2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL4756954 0.81 FFAR2 (0.46) FFAR2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL4757209 0.80 MEN1 (0.46) FFAR2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL4757983 0.77 KDR (0.61) FFAR2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4757111 0.76 MEN1 (0.47) FFAR2SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL4757096 0.76 NPC1 (0.48) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL703520 0.76 FFAR2 (0.48) FFAR2SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4756653 0.74 POLB (0.40) FFAR2SMN1; SMN2NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC FFAR2 4045/4885SMN1; SMN2 3410/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.